{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T22:27:42Z","timestamp":1783117662718,"version":"3.54.6"},"reference-count":64,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>The global rise in obesity is linked to metabolic disorders, such as neuropathy and infertility. Our study aimed to analyze the effects of preconceptional weight loss in infertile women with obesity on peripheral sensory and cardiovascular autonomic nerve function, metabolic parameters, and the success of <jats:italic>in vitro<\/jats:italic> fertilization (IVF).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A retrospective cohort study included women with obesity and infertility undergoing weight optimization before IVF, alongside age-matched controls. Clinical and laboratory parameters, cardiovascular autonomic and peripheral sensory function, and body composition were evaluated before and following weight loss therapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Patients with obesity [n=58; mean \u00b1 SD; age: 33.1 \u00b1 5.42 years; body mass index (BMI): 39.3 \u00b1 6.90 kg\/m<jats:sup>2<\/jats:sup>] had higher resting blood pressure, prevalence of metabolic disorders, and medication usage than controls (n=45; age: 32.1 \u00b1 7.67 years; BMI: 21.1 \u00b1 2.02 kg\/m\u00b2). Laboratory findings indicated differences in blood cell counts, glucose metabolism markers, kidney and liver functions, and lipid profile between the groups. Cardiovascular autonomic function tests indicated impairment in Valsalva-ratio (1.4 \u00b1 0.22 vs. 1.5 \u00b1 0.23, p&amp;lt;0.001) and 30\/15 ratio (1.07 \u00b1 0.12 vs. 1.12 \u00b1 0.13, p&amp;lt;0.05) in patients with obesity. Peripheral sensory function tests revealed significant deterioration in vibration sense and the current perception threshold of the median nerve at 2000 Hz in patients with obesity, as compared to controls. Before and following weight loss therapy no statistically significant difference was found on cardiovascular autonomic and peripheral sensory function. Following weight loss therapy with lifestyle\/dietary intervention and liraglutide, 16 female patients with obesity attended the follow-up measurement. They achieved significant weight reduction (104.3 \u00b1 16.64 vs. 89.1 \u00b1 15.74 kg; p&amp;lt;0.05) and 8 became pregnant (5 via IVF, 3 spontaneously).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Peripheral sensory neuronal impairments were detected in infertile women with obesity compared to the controls with normal BMI. Cardiovascular autonomic dysfunction was revealed by 30\/15 and Valsalva-ratio in patients with obesity, suggesting the presence of parasympathetic dysfunction. Preconceptional weight loss improved metabolic parameters. Of the infertile female patients with obesity who reached their preconceptional target weight, 18.75% achieved spontaneous pregnancy without IVF, and 62.5% of those who underwent IVF successfully conceived.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2025.1548587","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T09:21:33Z","timestamp":1747732893000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["The impact of obesity and weight loss treatment on metabolic parameters, cardiovascular autonomic and sensory nerve function and in vitro fertilization outcomes in infertile women: a pilot study"],"prefix":"10.3389","volume":"16","author":[{"given":"Anna","family":"V\u00e1gv\u00f6lgyi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktor","family":"Vedelek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00f3ra","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalma","family":"Sz\u00f6ll\u0151si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szilvia","family":"Lada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attila","family":"Nemes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"Kempler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienn","family":"Menyh\u00e1rt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istv\u00e1n","family":"Baczk\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam\u00e1s","family":"V\u00e1rkonyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Csaba","family":"Lengyel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e1nos","family":"Z\u00e1dori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,20]]},"reference":[{"key":"B1","unstructured":"Prevalence of adult overweight and obesity"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-020-05085-9","article-title":"Diabetic neuropathy: what does the future hold","volume":"63","author":"Callaghan","year":"2020","journal-title":"Diabetologia"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2020.03.025","article-title":"Central obesity is associated with neuropathy in the severely obese","volume":"95","author":"Callaghan","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2016.3745","article-title":"Association between metabolic syndrome components and polyneuropathy in an obese population","volume":"73","author":"Callaghan","year":"2016","journal-title":"JAMA Neurol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1386147","article-title":"Cardiovascular autonomic and peripheral sensory neuropathy in women with obesity","volume":"15","author":"Keller","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-024-06242-0","article-title":"Cardiovascular autonomic neuropathy in diabetes: an update with a focus on management","volume":"67","author":"Eleftheriadou","year":"2024","journal-title":"Diabetologia. Published Online August"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1379109","article-title":"Endometrium development patterns and BMI groups among in vitro fertilization patients; prognostic aspects","volume":"15","author":"Vedelek","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.5935\/1518-0557","article-title":"Obese women and in vitro fertilization: results","volume":"17","author":"Koatz","year":"2022","journal-title":"JBRA Assist Reprod"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j1","article-title":"Obesity and pregnancy: mechanisms of short term and long term adverse consequences for mother and child","volume":"356","author":"Catalano","year":"2017","journal-title":"BMJ"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1479-828X.2011.01343.x","article-title":"Diet and IVF pilot study: short-term weight loss improves pregnancy rates in overweight\/obese women undertaking IVF","volume":"51","author":"Moran","year":"2011","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/cob.12048","article-title":"Weight loss improves reproductive outcomes in obese women undergoing fertility treatment: a randomized controlled trial","volume":"4","author":"Sim","year":"2014","journal-title":"Clin Obes"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2017.06.019","article-title":"Weight decrease improves live birth rates in obese women undergoing IVF: a pilot study","volume":"35","author":"Espin\u00f3s","year":"2017","journal-title":"Reprod BioMed Online"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2014.03.006","article-title":"Physical activity before IVF and ICSI cycles in infertile obese women: an observational cohort study","volume":"29","author":"Palomba","year":"2014","journal-title":"Reprod BioMed Online"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/obr.12217","article-title":"Does weight loss in overweight or obese women improve fertility treatment outcomes? A systematic review","volume":"15","author":"Sim","year":"2014","journal-title":"Obes Rev"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad463","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"108","author":"Teede","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmz013","article-title":"The effect of physical activity on reproductive health outcomes in young women: a systematic review and meta-analysis","volume":"25","author":"Mena","year":"2019","journal-title":"Hum Reprod Update"},{"key":"B17","unstructured":""},{"key":"B18","unstructured":"Magyarorsz\u00e1g Hivatalos\n              K\u00f6zl\u00f6nye\n            \n          \n          \n          2023"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2009.09.009","article-title":"International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) revised glossary of ART terminology, (2009)","volume":"92","author":"Zegers-Hochschild","year":"2009","journal-title":"Fertil Steril"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.285.6346.916","article-title":"Diagnosis and management of diabetic autonomic neuropathy","volume":"285","author":"Ewing","year":"1982","journal-title":"Br Med J (Clin Res Ed)"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.8.5.491","article-title":"The value of cardiovascular autonomic function tests: 10 years experience in diabetes","volume":"8","author":"Ewing","year":"1985","journal-title":"Diabetes Care"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.1239","article-title":"Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management","volume":"27","author":"Spallone","year":"2011","journal-title":"Diabetes Metab Res Rev"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2015.04.018","article-title":"Assessment of Peripheral Neuropathy Using Measurement of the Current Perception Threshold with the Neurometer\u00ae in patients with type 1 diabetes mellitus","volume":"109","author":"Lv","year":"2015","journal-title":"Diabetes Res Clin Pract"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.65.5.743","article-title":"Measuring vibration threshold with a graduated tuning fork in normal aging and in patients with polyneuropathy. European Inflammatory Neuropathy Cause and Treatment (INCAT) group","volume":"65","author":"Martina","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1411892","article-title":"SCALE obesity and prediabetes NN8022\u20131839 study group. A randomized, controlled trial of 3.0 mg of liraglutide in weight management","volume":"373","author":"Pi-Sunyer","year":"2015","journal-title":"N Engl J Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1603827","article-title":"LEADER steering committee; LEADER trial investigators. Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"B27","volume-title":"Global recommendations on physical activity for health","year":"2010"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-8223(03)00971-4","article-title":"Nutrition Care Process and Model: ADA adopts road map to quality care and outcomes management","volume":"103","author":"Lacey","year":"2003","journal-title":"J Am Diet Assoc"},{"key":"B29","volume-title":"SMART PLATE","year":"2020"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dead150","article-title":"Evidence-based guideline: unexplained infertility\u2020","volume":"38","author":"Romualdi","year":"2023","journal-title":"Hum Reprod"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.22074\/ijfs.2018.5232","article-title":"Hypertensive disorders in pregnant women receiving fertility treatments","volume":"12","author":"Barekat","year":"2018","journal-title":"Int J Fertil Steril"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dead234","article-title":"Impaired glucose tolerance and cardiovascular risk factors in relation to infertility: a Mendelian randomization analysis in the Norwegian Mother, Father, and Child Cohort Study","volume":"39","author":"Hern\u00e1ez","year":"2024","journal-title":"Hum Reprod"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2021.02.009","article-title":"Fertility outcomes in women with pre-existing type 2 diabetes-a prospective cohort study","volume":"116","author":"Mattsson","year":"2021","journal-title":"Fertil Steril"},{"key":"B34","doi-asserted-by":"publisher","first-page":"318","DOI":"10.21037\/atm-22-714","article-title":"The relationship between polycystic ovary syndrome and infertility: a bibliometric analysis","volume":"10","author":"Zhuang","year":"2022","journal-title":"Ann Transl Med"},{"key":"B35","article-title":"Hirsutism in women","volume":"100","author":"Matheson","year":"2019","journal-title":"Am Fam Physician"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2023.12.038","article-title":"Subclinical hypothyroidism in the infertile female population: a guideline","volume":"121","year":"2024","journal-title":"Fertil Steril"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s13679-021-00433-1","article-title":"Vitamin D and obesity: current evidence and controversies","volume":"10","author":"Karampela","year":"2021","journal-title":"Curr Obes Rep"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/obr.12239","article-title":"Obesity and vitamin D deficiency: a systematic review and meta-analysis","volume":"16","author":"Pereira-Santos","year":"2015","journal-title":"Obes Rev"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.116.136879","article-title":"Vitamin D status and weight loss: a systematic review and meta-analysis of randomized and nonrandomized controlled weight-loss trials","volume":"104","author":"Mallard","year":"2016","journal-title":"Am J Clin Nutr"},{"key":"B40","doi-asserted-by":"publisher","first-page":"dgae775","DOI":"10.1210\/clinem\/dgae775","article-title":"Weight Loss Induces Changes in Vitamin D Status in Women with Obesity but not in Men: a Randomized Clinical Trial","author":"Holt","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00379.2020","article-title":"Adipose tissue inflammation and metabolic dysfunction in obesity","volume":"320","author":"Kawai","year":"2021","journal-title":"Am J Physiol Cell Physiol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S294368","article-title":"Markers of chronic inflammation in overweight and obese individuals and the role of gender: A cross-sectional study of a large cohort","volume":"14","author":"Cohen","year":"2021","journal-title":"J Inflammation Res"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1111\/obr.12003","article-title":"Obesity and C-reactive protein in various populations: a systematic review and meta-analysis","volume":"14","author":"Choi","year":"2013","journal-title":"Obes Rev"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1155\/2008\/834153","article-title":"Platelet counts and platelet activation markers in obese subjects","volume":"2008","author":"Samocha-Bonet","year":"2008","journal-title":"Mediators Inflammation"},{"key":"B45","article-title":"Is it necessary to consider obesity when constructing norms for hemoglobin or when screening for anemia using hemoglobin levels","volume":"28","author":"Al-Hashem","year":"2007","journal-title":"Saudi Med J"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1111\/obr.12323","article-title":"Obesity and iron deficiency: a quantitative meta-analysis","volume":"16","author":"Zhao","year":"2015","journal-title":"Obes Rev"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/edm2.v5.6","article-title":"The association between obesity with serum levels of liver enzymes, alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase and gamma-glutamyl transferase in adult women","volume":"5","author":"Jalili","year":"2022","journal-title":"Endocrinol Diabetes Metab"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2013.04.001","article-title":"Obesity, adiposity, and dyslipidemia: a consensus statement from the National Lipid Association","volume":"7","author":"Bays","year":"2013","journal-title":"J Clin Lipidol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3390\/nu11040882","article-title":"The type 2 diabetes susceptibility PROX1 gene variants are associated with postprandial plasma metabolites profile in non-diabetic men","volume":"11","author":"Adamska-Patruno","year":"2019","journal-title":"Nutrients"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.657856","article-title":"Serum uric acid is a mediator of the association between obesity and incident nonalcoholic fatty liver disease: A prospective cohort study","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.5539\/gjhs.v13n1p103","article-title":"Correlation between uric acid and non-alcoholic steatohepatitis (NASH) occurred in obesity and non-obesity","volume":"13","author":"Rasdiana","year":"2020","journal-title":"Glob J Health Sci"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2019.09.010","article-title":"Sex hormone-binding globulin and polycystic ovary syndrome","volume":"499","author":"Zhu","year":"2019","journal-title":"Clin Chim Acta"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-0670","article-title":"Racial differences in the association between sex hormone-binding globulin and adiposity in premenopausal women: the BioCycle study","volume":"33","author":"Yeung","year":"2010","journal-title":"Diabetes Care"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1007\/s13300-019-00693-0","article-title":"Cardiac autonomic neuropathy in obesity, the metabolic syndrome and prediabetes: A narrative review","volume":"10","author":"Williams","year":"2019","journal-title":"Diabetes Ther"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0803395","article-title":"Retention rates and weight loss in a commercial weight loss program [published correction appears in Int J Obes (Lond). 2007 Feb;31(2):394","volume":"31","author":"Finley","year":"2007","journal-title":"Int J Obes (Lond)"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11112998","article-title":"Efficacy of liraglutide in non-diabetic obese adults: A systematic review and meta-analysis of randomized controlled trials","volume":"11","author":"Barboza","year":"2022","journal-title":"J Clin Med"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2022.04.027","article-title":"Liraglutide 3 mg on weight, body composition, and hormonal and metabolic parameters in women with obesity and polycystic ovary syndrome: a randomized placebo-controlled-phase 3 study","volume":"118","author":"Elkind-Hirsch","year":"2022","journal-title":"Fertil Steril"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/78.2.228","article-title":"Percentage body fat ranges associated with metabolic syndrome risk: results based on the third National Health and Nutrition Examination Survey (1988-1994)","volume":"78","author":"Zhu","year":"2003","journal-title":"Am J Clin Nutr"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2025.104941","article-title":"Body composition in female infertility from body mass index to body composition in female infertility","author":"Dar\u0131c\u0131","year":"2025","journal-title":"Reprod BioMedicine Online"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61375-1","article-title":"NN8022\u20131807 Study Group. Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study","volume":"374","author":"Astrup","year":"2009","journal-title":"Lancet"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1093\/hropen\/hoac022","article-title":"ART in Europe, 2018: results generated from European registries by ESHRE","volume":"2022","author":"Wyns","year":"2022","journal-title":"Hum Reprod Open"},{"key":"B62","article-title":"Effect of antihypertensive therapy on sympathetic nervous system activity in patients with essential hypertension","volume":"43","author":"Chernow","year":"1984","journal-title":"Fed Proc"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(75)90046-1","article-title":"Central inhibitory effect of alpha-methyldopa on blood pressure, heart rate and body temperature of renal hypertensive rats","volume":"31","author":"Nijkamp","year":"1975","journal-title":"Eur J Pharmacol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-020-00796-5","article-title":"Drug-related orthostatic hypotension: beyond anti-hypertensive medications","volume":"37","author":"Rivasi","year":"2020","journal-title":"Drugs Aging"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1548587\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T09:21:36Z","timestamp":1747732896000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1548587\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,20]]},"references-count":64,"alternative-id":["10.3389\/fendo.2025.1548587"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1548587","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,20]]},"article-number":"1548587"}}